In the four years since the U.S. Supreme Court's monumental decision in Federal Trade Commission v. Actavis, pay-for-delay lawsuits have been on the cutting edge of antitrust law, but attorneys who work in the area say there are signs that the litigation is waning as pharmaceutical companies turn away from reverse payment settlements and drug buyers mull over adverse rulings.
Less than two weeks after British Airways announced that it was under investigation for alleged price-fixing, a slew of class action lawsuits has already hit the major carrier, as well as other airlines.
More U.S. companies are slipping arbitration clauses into their business contracts, but the putative class action against shipping company Stolt-Nielsen S.A. challenges the common assumption that arbitration is an appropriate and less costly venue for resolving antitrust disputes.
Taking the next step toward revamping its competition rules, China said this week it will create a special panel of government officials, legal experts and economists in a bid to enforce a proposed anti-monopoly law that is slated for passage in the near future.
Having worked hard in recent years to establish itself as one of the top antitrust practices, international law firm Freshfields Bruckhaus Deringer is now looking to a new pair of lawyers to help build upon that success.
In a move that could open the floodgates for controversial patent settlement deals between brand-name and generic drug companies, the nation’s highest court Monday turned down the U.S. Federal Trade Commission’s appeal in the closely watched Schering-Plough case.
By deciding to weigh in on a timber buying dispute, the U.S. Supreme Court Monday signaled it’s willing to determine whether it is an antitrust violation for companies to buy materials at inflated prices with the intent of eliminating competition.
The U.S. Supreme Court agreed on Monday to hear an appeal by U.S. telecommunications giants on a motion to dismiss a class action lawsuit against them that alleges antitrust violations.
The U.S. Department of Justice has issued subpoenas to four orthopedic device makers over possible antitrust violations, a development that sent stock prices tumbling across the orthopedic industry as investors mulled the prospect of upheaval in the multi-billion dollar market.
As low-fare airlines jockey for a piece of the European market, rumors of alleged price-fixing continue to plague an industry where the threat of increased competition might have led to illegal cartel behavior.
In a case that could influence how the U.S. Federal Trade Commission rules on future settlement agreements over generic drugs, Bristol-Myers Squibb, Sanofi-Aventis and Apotex have altered their settlement over the blockbuster blood thinner Plavix.
European Competition Commissioner Neelie Kroes announced reforms Friday to the European Union’s policies on state aid aimed at fostering innovation. Kroes said she hoped the reforms would be implemented by the end of 2006.
An offhand comment by European Commission honcho Neelie Kroes has suddenly put Europe’s telecommunications giants on notice, raising fears that a sweeping antitrust investigation of the industry is in the works.
The U.S. Department of Justice is seeking to hold the American Bar Association in civil contempt for allegedly violating provisions of a 1996 antitrust consent decree over its involvement in law school accreditation.
Two of the nation’s largest funeral home operators have asked the Federal Trade Commission for a consent decree on a proposed merger that has raised stiff objections from industry professionals.
In a significant compromise, French lawmakers voted on Thursday in favor of a copyright law that would force companies to make their music players compatible with similar products, but not force them to share copy-protection formats with rivals.
When Axinn, Veltrop & Harkrider LLP partner Lauren Albert began practicing antitrust law in 1988, her female colleagues in the field were scarce, but she was lucky to have the guidance of several invaluable mentors. Nearly two decades later, she hopes to provide that camaraderie to women in similar shoes by spearheading a coalition of female antitrust attorneys in New York City.
Already under the competition microscope for its air cargo activities, British Airways PLC is now facing a new probe into whether the carrier colluded to fix passenger fare increases industrywide.
With a generic version of cholesterol drug Zocor hitting shelves Thursday, an offer by Merck & Co. to provide the drug for below the generic price has some accusing the pharmaceutical company of predatory pricing.
Advanced Micro Devices Inc. fired off the latest salvo in its antitrust battle with Intel Corp., serving subpoenas on 32 third parties, including Wal-Mart, Staples, Toys-R-Us and Costco.
Within the next few weeks, regulators expect to complete their review of Adelphia Communications Corp.’s plan to sell its assets to Time Warner Inc. and Comcast Corp., bringing the company one step closer to the end of a long stay in Chapter 11 bankruptcy protection.